Medicare Enrolled

Dr. Sharron Acosta, M.D.

Ophthalmology · Seguin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
908 E COURT ST, Seguin, TX 78155
8303793937
In practice since 2006 (19 years)
NPI: 1467465849 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Acosta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Acosta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Acosta

Dr. Sharron Acosta is an ophthalmology in Seguin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Acosta performed 974 Medicare services across 671 unique beneficiaries.

Between the years covered by Open Payments, Dr. Acosta received a total of $12,764 from 39 pharmaceutical and/or device companies across 147 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Acosta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 974 Medicare services$ $12,764 industry payments

Medicare Practice Summary

Medicare Utilization ↗
974
Medicare services
Bottom 30% in TX for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
671
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Microfluid analysis of tears323$22$65
Office visit, established patient (30-39 min)162$77$150
Office visit, established patient (20-29 min)152$60$95
Retinal imaging (OCT scan)131$27$125
New patient office visit (45-59 min)50$108$180
Retinal photography (fundus photo)41$23$125
Optic nerve imaging (OCT scan)32$24$125
Exam of the internal drainage system of eye30$18$77
Visual field test, extended29$46$200
Placement of amniotic membrane on eye surface for wound healing24$989$1,800
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,764
Total received (2018-2024)
Avg $1,823/year across 7 years
Top 10% in TX for ophthalmology
39
Companies
147
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,764 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,009
2023
$1,909
2022
$2,059
2021
$1,743
2020
$711
2019
$3,180
2018
$1,154

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Johnson & Johnson Surgical Vision, Inc.
$2,443
Alcon Vision LLC
$1,215
Ocular Therapeutix, Inc.
$883
Bausch & Lomb, a division of Bausch Health US, LLC
$792
Carl Zeiss Meditec USA, Inc.
$590
AbbVie Inc.
$527
ABBVIE INC.
$461
Glaukos Corporation
$382
BIOTISSUE HOLDINGS, INC.
$381
Sight Sciences, Inc.
$379
Eyevance Pharmaceuticals LLC
$363
Bausch & Lomb Americas Inc.
$353
TissueTech, Inc.
$337
Allergan, Inc.
$294
Kala Pharmaceuticals, Inc.
$249
Genentech USA, Inc.
$242
Alcon Laboratories Inc
$237
BioTissue Holdings, Inc.
$219
Oyster Point Pharma, Inc.
$216
BIOTISSUE HOLDINGS INC.
$203
Allergan Inc.
$197
NEW WORLD MEDICAL,INC.
$190
Regeneron Pharmaceuticals, Inc.
$150
Sun Pharmaceutical Industries Inc.
$148
Astellas Pharma US Inc
$127
EyePoint Pharmaceuticals US, Inc.
$124
Dompe US, Inc.
$122
Amgen Inc.
$122
Heidelberg Engineering, Inc.
$121
Ivantis, Inc
$118
Novartis Pharmaceuticals Corporation
$111
Aerie Pharmaceuticals, Inc.
$98
Thea Pharma Inc.
$98
Ziemer USA
$80
GLAUKOS CORPORATION
$71
Alimera Sciences, Inc.
$63
Omeros Corporation
$24
LENSAR, Inc.
$19
Shire North American Group Inc
$14
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
ACTIVEFOCUS · ARGOS · AcrySof · AcrySof IQ VIVITY IOL · BROMSITE · Catalys Laser System · Cequa · CyPass · DEXTENZA · DEXYCU · DURYSTA · ENVISTA TORIC · EYLEA HD · EYSUVIS · HYDRUS Microstent · Hydrus · ILUVIEN · INVELTYS · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · Izervay · Kahook Dual Blade · LENSAR LASER SYSTEM · LOTEMAX SM · LUMIGAN · Lucentis · MIEBO · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · OZURDEX · Omidria · One Series Ultra · One Series Ultra IOL Delivery System · PROKERA · PROLENSA · PanOptix · Prokera · RESTASIS · RESTASIS MULTIDOSE · Rocklatan · Simbrinza · Spectralis · TEARCARE SYSTEM · TECNIS IOL · TEPEZZA · TYRVAYA · TearCare SmartLid · Tecnis 1-piece IOL · Tecnis Symfony IOL · Tobradex ST · UBRELVY · VABYSMO · VICTUS · VUITY · VYZULTA · VisuMax · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · Z8 · ZYLET · Zerviate · enVista MX60 IOL · iStent inject Trabecular Micro-Bypass Stent System · iStent inject W · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for ophthalmology in TX.

Equivalent to $1,311 per 100 Medicare services performed
Looking for a ophthalmology in Seguin?
Compare ophthalmologys in the Seguin area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
14
Per 100K population
7.8
County median income
$93,776
Nearest hospital
GUADALUPE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Acosta is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Acosta experienced with microfluid analysis of tears?
Based on Medicare claims data, Dr. Acosta performed 323 microfluid analysis of tears services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Acosta receive payments from pharmaceutical companies?
Yes. Dr. Acosta received a total of $12,764 from 39 companies across 147 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Acosta's costs compare to other ophthalmologys in Seguin?
Dr. Acosta's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Acosta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →